- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
Breaking Barriers: An Egyptian Immigrant's Journey with ALL
In this episode of the “CURE Talks Cancer” podcast, we spoke with Bishoy Tadros, who went on to break barriers after he was diagnosed with acute lymphoblastic leukemia at the age of 3 and immigrated to the United States from Egypt to receive treatment.
At the age of 3, Bishoy Tadros received a diagnosis of acute lymphoblastic leukemia and immigrated to the United States with him family to receive treatment.
After moving to Los Angeles and then to Long Island, New York, Tadros underwent varios aggressive surgeries and entered remission on his 13th birthday.
However, it wasn’t until 2017 that he was inspired to share his story. He pushed away from his comfort zone, entering to run the New York City Marathon and raising money for the Leukemia and Lymphoma Society — all of which helped him to realize the power of his personal story.
Tadros wrote a memoir, titled “Break Barriers,” to help individuals learn that setbacks are never instilled to define oneself, and that patience, perspective and purpose are key.
Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer
November 30th 2023Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Listen
Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy-Related Cancer
November 29th 2023The FDA announced rare instances of secondary diseases or cancers from CAR-T cell therapy, though this is not the first time that oncology treatments have been associated with secondary diseases.
Read More
